The antisickling agent, 5-hydroxymethyl-2-furfural: Other potential pharmacological applications

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• 5-hydroxymethyl-furfural (5-HMF) is an aromatic aldehyde investigated for two decades.
• Initial research in 2004 by the Safo group highlighted its potent antisickling activity.
• Preclinical and clinical studies support 5-HMF's efficacy in sickle cell disease (SCD).

Purpose of the Study:

• To review the therapeutic potential of 5-hydroxymethyl-furfural (5-HMF).
• To consolidate research on 5-HMF's sources, properties, safety, and ADME profiles.
• To explore the broad range of biological activities and potential disease applications of 5-HMF.

Main Methods:

• Literature review of studies on 5-hydroxymethyl-furfural (5-HMF).
• Analysis of preclinical and clinical data regarding 5-HMF's efficacy and safety.
• Compilation of research on 5-HMF's physicochemical properties and pharmacokinetic profiles.

Main Results:

• 5-HMF demonstrates significant antisickling activity, targeting red blood cell pathophysiology.
• Identified diverse pharmacological effects including anti-allergic, antioxidant, anti-hypoxic, anti-ischemic, cognitive enhancement, and anti-inflammatory properties.
• 5-HMF shows promise for treating various conditions such as SCD, cognitive disorders, anemia, hypoxia, and cancer.

Conclusions:

• 5-hydroxymethyl-furfural (5-HMF) is a versatile compound with broad therapeutic potential.
• Its established antisickling activity and other pharmacological effects warrant further investigation for treating multiple diseases.
• Comprehensive understanding of 5-HMF's properties, safety, and ADME is crucial for its clinical development.